Ethical and policy considerations for COVID-19 vaccination modalities: delayed second dose, fractional dose, mixed vaccines

Affiliations

• ¹ Blavatnik School of Government, Oxford University, Oxford, UK jonathan.wolff@bsg.ox.ac.uk.
• ² Philosophy and Classics, University of Ghana, Accra, Greater Accra, Ghana.
• ³ Centre for Ethics, Yenepoya University, Mangalore, Karnataka, India.
• ⁴ Department of Medical Ethics and Health Policy in the Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
• ⁵ Berman Institute of Bioethics, Johns Hopkins University, Baltimore, Maryland, USA.
• ⁶ Department of Microbiology, Tribhuvan University, Kirtipur, Kathmandu, Nepal.
• ⁷ Professor Emeritus, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
• ⁸ Department of Law, and Centre for Medical Ethics and Law, University of Hong Kong, Pok Fu Lam, Hong Kong.
• ⁹ Global Healthcare Consulting, New Delhi, India.
• ¹⁰ Department of Global Health, University of Washington, Seattle, Washington, USA.
• ¹¹ Law, Graduate Institute of International and Development Studies, Geneve, Switzerland.
• ¹² Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
• ¹³ Medical Ethics and History of Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran.
• ¹⁴ Howard College School of Law, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa.
• ¹⁵ Division of Clinical Public Health, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
• ¹⁶ Preventive Medicine Department, Faculty of Health Sciences, University of Western Ontario, London, Ontario, Canada.
• ¹⁷ Federal University of São Paulo, São Paulo, Brazil.
• ¹⁸ Indpendent consultant, Dakar, Senegal.
• ¹⁹ Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.